Spravato

Spravato (Esketamine) is an FDA-approved option for treatment-resistant depression, given only in certified clinics. MDDCare helps you find authorized providers, understand insurance rules, and access safe, effective care.

Living with PTSD can be overwhelming—but medication isn’t your only option. At MDDCare, we spotlight reliable, alternative treatments such as Transcranial Magnetic Stimulation (TMS) and Spravato (Esketamine), both FDA-cleared and offered by expert clinics across the U.S. Learn how these modern, non-invasive therapies are changing lives—and where you can find trusted care near you.

Spravato (Esketamine) provides hope for treatment-resistant depression when traditional antidepressants fail. MDDCare connects patients with trusted clinics across the USA, ensuring access to advanced, FDA-approved care alongside ongoing therapy.